Cybin Inc. Common Stock
HELP
Kedudukan dalam Saham
#11646
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Harga Saham
$10.30
Disegerakkan terakhir: 2026-08-11
Modal Pasaran
$638.32M
Perubahan (1 hari)
2.88%
Perubahan (1 tahun)
9,119.52%
Negara
CA
Perdagangan Cybin Inc. Common Stock (HELP)
Kategori
Healthcare
Sejarah harga saham bagi Cybin Inc. Common Stock (HELP)
Harga penutupan tertinggi: $0.12 pada 2023-10-01
Harga penutupan terendah: $0.40 pada 2021-06-01
Harga penutupan terendah: $0.40 pada 2021-06-01
Sejarah harga saham Cybin Inc. Common Stock dari 2021 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2023 | 81.70% |
| 2022 | -76.32% |
| 2021 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.17 | -4.24% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
